Search alternatives:
nm decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
e decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
12 nm » 10 nm (Expand Search), 12 mm (Expand Search), 12 m (Expand Search)
_ e » _ em (Expand Search)
nm decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
e decrease » _ decreased (Expand Search), _ decreases (Expand Search), a decreased (Expand Search)
12 nm » 10 nm (Expand Search), 12 mm (Expand Search), 12 m (Expand Search)
_ e » _ em (Expand Search)
-
1
HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching.
Published 2015“…<p><b>A,B:</b> Gene knockdown of EZH2 and SUZ12 was confirmed by qPCR. <b>C,D:</b> In HRMECs transfected with EZH2 siRNA in HG, miR-200b and VEGF were not significantly different from HG+control siRNA but decreased compared to NG+control siRNA. …”
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Loss of p115RhoGEF decreases junctional E-cadherin and promotes protrusions.
Published 2014Subjects: -
11
SU9518 decreases cell proliferation and restore normal remodeling in eNOS (−/−) mice.
Published 2012“…(E) PDGF-BB receptor tyrosine kinase inhibitor decreases immunoreactive survivin levels in LC of eNOS (−/−) mice, compared to vehicle treated eNOS (−/−) mice (left panel). …”
-
12
-
13
-
14
Translocation of EHEC-Hly to mitochondria results in cytosolic cytochrome c release and ΔΨ<sub>m</sub> decrease.
Published 2013“…No cytochrome c was detected at any time in cytosol of control cells (control cyto). (<b>E, F</b>) HBMEC (<b>E</b>) and Caco-2 cells (<b>F</b>) were incubated with EHEC-Hly-containing or EHEC-Hly-free OMVs as indicated in A and B and ΔΨ<sub>m</sub> was determined by uptake of TMRE using flow cytometry. …”
-
15
-
16
-
17
-
18
Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches).
Published 2015Subjects: -
19
TEM images of (a) amlodipine (b) hydrochlorothiazide and (c) candesartan nanoparticles.
Published 2015Subjects: -
20